Chief Physician Houaihua
Houaihua, chief physician, national key specialist Yantai traditional Chinese medicine hospital oncology department director. He graduated from Shanghai University of Traditional Chinese Medicine and is a clinical graduate student of Chinese medicine. Senior Chinese medicine experts at the national level academic experience heirs, national key specialist academic leaders and academic leaders. Member of the Chinese Traditional Chinese and Western Medicine Combined Oncology Professional Committee, member of the Oncology Professional Committee of the Chinese Traditional Chinese Medicine Promotion Association, member of the Executive Committee of the Chinese and Western Medicine Combined Oncology Expert Committee of the Chinese Medical Association, member of the Shandong Province Tumor Chemotherapy Professional Committee, member of the Shandong Provincial Chinese and Western Medicine Combined Oncology Professional Committee, chairman of the Oncology Professional Committee of the Yantai City Association.
For more than 20 years, he has been engaged in clinical research on the combination of Chinese and Western medicine to treat systemic tumors and diseases of the digestive system. He has created integrated Chinese and Western medicine to balance the viscera, immune transformation, siege dissipation, effective methods for comprehensive treatment of tumors, and Chinese medicine to reduce poison and increase efficiency. The comprehensive treatment of pain-free chemotherapy. He specializes in the treatment of lung cancer, hepatobiliary cancer, breast cancer, stomach cancer, colorectal cancer, pancreatic cancer, esophageal cancer, lymphoma, brain tumor, bladder cancer, and other types of cancer, and has reached the advanced level of treatment in China.
In recent years, 20 new technologies have been developed, nearly 20 papers have been published, and 5 monographs have been written. Clinical research topics
Doctor shao hongmin.
Shao hongmin, chief physician, director of the department of oncology, TCM hospital, yantai city, China. Graduated from Harbin medical university, clinical graduate of traditional Chinese medicine. I’m also a member of the oncology professional committee of the association of traditional Chinese and western medicine in shandong province and a part-time adjunct professor in shandong university of traditional Chinese medicine.
In the oncology work more than 20 years, pay attention to the standardization of the comprehensive treatment of tumor, is good at by combining traditional Chinese and western medicine treatment of gastric cancer, colorectal cancer, lung cancer, liver cancer, gynecological tumors and other solid tumors, especially for the early screening for gastric cancer, gastric cancer before the disease of traditional Chinese medicine recuperates the maintenance, curative effect is outstanding, numerous clinical benefit patients back to health. In a unique feature of middle-late gastric cancer treatment, western medicine treatment of precision, research and development of gastric cancer. 1, no. 2, there are series of prescription, external party, etc., the third phase of gastric cancer B lived five years a lot of, can long-term survival with tumor distant metastasis patients, quality of life. Complete the whole management plan of gastric cancer.I have rich experience in emergency treatment for patients with tumor. Other traditional Chinese medicine, such as nasopharyngeal cancer, Chinese traditional Chinese medicine for nasal spray, traditional Chinese medicine perfusion therapy for bladder cancer, lung cancer and lung cancer, and oral therapy of molecular targeted drugs, etc., are all good. Righting anti-cancer detoxification therapy in the treatment of liver cancer, research internal and external use, can make the efficacy of direct liver cancer nodule lesions, the water swelling, in addition to expanding the pain, and side effects of light, can be received and the therapeutic effect of curing.
I have published more than ten academic papers, two of which are internationally influential SCI papers. Oncology medical monograph two. The treatment of malignant tumor with stasis and analgesia has been patented by two countries. Research and treatment of malignant ascites drainage device won two national invention patent, host has completed the centralizer antidiarrheal soup decoction of the clinical study on treatment of diarrhea caused by chemotherapy research topic, passed the appraisal of scientific research, and obtained the Chinese medicine institute of science and technology of shandong province third prize. In this paper, the research on the clinical study on the treatment of gastric cancer ascites with the treatment of gastric cancer with the treatment of distension and distention of distension and the improvement of the survival quality of patients with advanced gastric cancer by electronic moxibustion and moxibustion is being completed.
She was born in 1969, graduated from the Department of clinical medicine of Binzhou Medical University in 1992.After her graduation, she has been engaged in the Department of cancer medicine. She is currently the director of the second Department of cancer in the Yantai Hospital of traditional Chinese medicine,deputy chief physician.
She said, the minimally invasive technique eliminates the early tumor in the bud and reduces the tumor load for the late patients.Traditional Chinese medicine can prevent tumors and improve their living conditions.She is good at using the combination of traditional Chinese and Western medicine,painless prolongation of the life of the patient.
She specializes in the treatment and prevention of gastric cancer, lung cancer, breast cancer, colon cancer, liver cancer, lymphoma, multiple myeloma and chronic hematological diseases.She can master the internal jugular vein, subclavian vein and femoral vein catheterization, ultrasound guided percutaneous transhepatic biliary drainage and percutaneous renal pelvis puncture drainage, ultrasound and CT guided liver, lung, adrenal and other important organs and neck, retroperitoneal lymph node puncture etc. biopsy technique, microwave ablation, (radioactive iodine -125) tumor implantation,Microwave ablation of thyroid nodules, myoma of uterus, breast nodules, and vacuum assisted circumcision of breast nodules.
She is good at the use of traditional Chinese medicine in the middle and after the treatment of minimally invasive treatment.
She is a member of the Gerontological Society of Specialized Committee Chinese treatment in elderly cancer palliative, combining traditional Chinese and Western medicine Chinese Specialized Committee member, China Journal of cancer minimal invasive tumor therapy committee "minimally invasive tumor and individualized treatment expert committee standing committee, Yantai Institute of traditional Chinese medicine tumor Specialized Committee vice chairman, Yantai City Specialized Committee member of tumor chemotherapy. Shandong province blood disease in the combination of Western medicine treatment of the Standing Committee of the Specialized Committee.
She published in the National Journal of relevant academic papers: 1. Clinical observation of Shen Cao granule in the treatment of thrombocytopenia caused by GC chemotherapy in non small cell lung cancer; 2.A summary of traditional Chinese medicine in the prevention and treatment of thrombocytopenia after chemotherapy; 3.Effect of Tanreqing Injection on tumor hyperthermia; 4. Diagnosis and treatment of eye metastasis of breast cancer; 5.Study on the increase of "AFP" "CEA" by oral "mifepristone"; 6,The diagnosis and treatment of simple cutaneous anaplastic large cell lymphoma;7.Observation of the effect of AcAG regimen induced differentiation in the treatment of acute myeloid leukemia;8. Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum based anticancer reagents.She edited 3 books, three utility model patents,participate in the "KLT plus best supportive therapy and simple the best support treatment for elderly cancer patients on survival by the Yantai Municipal Science and Technology Progress Award. Shandong provincial science and technology development program funded project:clinical observation on the prevention and treatment of thrombocytopenia induced by chemotherapy of solid tumor based on the theory of " body fluid and blood sharing the same origin", has been identified by experts and is currently in the process of awarding the prize.
Dr Ling ling Dai
Associate chief physician,work in the traditional Chinese medical hospital of yantai,deputy director of the four Oncology Department,the Committee of China Association of Traditional Chinese Medicine Commission on cancer,third committee member of the Expert Committee for oncology of the Chinese Medical Doctor Association branch of Integrated Chinese and Western Medicine ,etc. In the tumor treatment work for nearly 20 years ,Learn from the great masters of TCM.
There are unique views in the combination of traditional Chinese and modern medicine for malignant tumors of the system.There are accumulated rich experiences of the anti recurred and metastased ,maintenance therapy of the advanced malignant tumors, in the colorectal cancer especially ,By private order ,adopt individualized and accurate treatment to greenly and efficiently treatment. In the TCM technology,experting in the system of dialectical sphygmology, acupuncture and medicine, Ziwuliuzhu acupuncture,Medicinal dishes, Fu's subcutaneous needling,the TCM five element music,etc.In modern medicine, using the latest international and most standard guidelines for the diagnosis and treatment of cancer flexibly, experting in all kinds of puncture and biopsy, the overall systematic therapy is combined with the local treatment.
At present, there are 9 papers published in the national core periodicals, 2 papers in SCI, 2 books, 3 patents, 1 items the third prize of scientific and technological advance.
SCI论文：1、The Plasma Level of ALT Can Predict the Metabolic Rate of Arctigenin Derivative 2017(3) 《Latin American Journal of Pharmacy》；2、Expression of PRR11 protein and its correlation with pancreatic cancer and effect on survival 2017 (6) 《Oncology Letters》。
专利：1、一种治疗中晚期胰腺癌的中药复方制剂 专利号ZL201310028620.1 2、一种治疗晚期大肠癌的中药复方制剂 专利号ZL201210561474.4；3、一次性中药外敷贴膜 专利号ZL201120067166.7
PhD , Deputy director of the Office,Major in Clinical and research work on prevention and treatment of common malignant tumors, such as breast cancer. Research project such as《microRNA-34a suppresses the breast cancer development via targeting Wnt1 in Wnt/β-catenin pathway》,《Clinical research of Bu Zhong Yiqi Decoction Combined with electronic moxibustion on the prevention and treatment of myelosuppression induced by chemotherapy》，《Zhibaidihuangwan regulation on the proliferation of estrogen receptor positive breast cancer cells and the effects of estrogen signaling pathway》, etc。Published papers such as《microRNA-34a suppresses the breast cancer development via targeting Wnt1 in Wnt/β-catenin pathway》，《Observation of the curative effect of Yangzhong Fuzheng decoction combined with chemotherapy in the treatment of advanced malignant tumors》, etc. By years of research and Practice, accumulated rich experience in diagnosis and treatment of common malignant tumor such as breast cancer. Inheriting the experience of famous TCM physician, created of diagnosis and treatment ideas of “overall concept and yin and yang theory”, “strengthening the body resistance while kill the tumor”, A very good clinical effect has been achieved.
主要从事乳腺癌等常见恶性肿瘤防治的临床及研究工作。目前任职科室副主任，兼职中国老年学和老年医学会肿瘤康复分会委员，山东省中医药学会肿瘤分会委员、烟台市中医药学会肿瘤分会委员，主持研究项目包括山东省中医药科技发展计划项目《补中益气汤联合电子艾灸防治化疗所致骨髓抑制的临床研究》，烟台市科技计划项目《知柏地黄丸对雌激素受体阳性乳腺癌细胞增殖的调节及对雌激素信号通路的影响》等5项，发表论著包括《microRNA-34a suppresses the breast cancer development via targeting Wnt1 in Wnt/β-catenin pathway》、《洋虫扶正汤联合化疗治疗中晚期恶性肿瘤的疗效观察》等8篇，出版《感染性疾病与肿瘤学》等专著2部，经过多年的研究及实践，对乳腺癌等常见恶性肿瘤的诊治积累了丰富经验，并在传承国家级名老中医李佩文教授、孙敏教授，西苑医院杨宇飞教授，山东省名中医侯爱画教授等中医大家学术经验的基础上，形成了整体阴阳入手，扶正驱邪并重的诊疗思路，取得了非常好的临床疗效。
Deputy chief physician, is the chief of the 1st department of Tumor of Yantai Hospital of Traditional Chinese Medicine.
She is a member of the Tumor Branch in China Association of Chinese Medicine, an executive member of Elderly Tumor Specialized Committee in Gerontological Society of China, a member of a council of the Oncology Branch in China Medical Association of Minorities and the Palliative Treatment and Research Specialized Committee in the World China Federation of Chinese Medicine Societies, a member of the Tumor Specialized Committee in the Institute of Shandong Traditional Chinese and Western medicine, the secretary of the Tumor Specialized Committee in Yantai Institute of traditional Chinese Medicine, etc. She has been devoted herself to the clinical work for more than 20years, after studying under Pro. Hou Aihua, Pro. Liu Luming, Pro. Xu ling, Pro. Sunmin and Pro. Huang huang. She is expert in treating gastric cancer, lung cancer, liver cancer, breast cancer, gynecological cancer, pancreatic cancer and other malignant tumor by Combining the Traditional Chinese Mdeicine and Western Medicine. And she is also skilled in minimally-invasive diagnosis and treatment technology, such as the tumor puncture biopsy, tumor microwave ablation, radioactive particle implantation and chemical ablation, etc.
After gathering and innovating, she summarized the unique view in the treatment of malignant tumor with combination of the traditional Chinese medicine and the Western medicine. Under the guidance of the view, by organism combination of treatment of the traditional Chinese medicine with surgery, chemotherapy, targeted, minimally invasive treatment, the patients’ quality of lives have been improved, and the survival period have been prolonged. She is skilled in treating lung cancer by using Chinese herbal paste, herbal tea, moxibustion, Chinese medicine medicated diet and acupoint injection, which leads to prolong the survival period of the patients especially in those who are in early lesions of lung cancer, and improve the carcinomatous constitution. She is also good at individualized treatment by formulating and using the prevention and control system of lung cancer under the constitution identification of the lung cancer. She also advocates the view of Tumor-Survival by applying treatment of traditional Chinese medicine whichleads toprolong the survival period of the advanced lung cancer. Also she developed the Yisui Shengbanfang Decoction, Fuzheng Shengbai Gaofang, Xuanfei zhisou Dowder, which is widely used in clinical work.
She participated in editing 3 books and published 2 articles of SCI and more than 10 articles in core journals, and got 1 invention patents. She also hosted or participated in 3 national level research or projects, several provincial and municipal scientific research or project, and got 3 science and technology achievement awards.